Intra-ovarian regulation of follicular maturation is modulated by various factors. Among these, growth factors are important local actors. We examined the immunohistochemical localization of transforming growth factor alpha (TGF-α), epidermal growth factor (EGF) and epidermal growth factor receptor (EGF-R) in 18 human ovaries. The concentration of TGF-α and EGF in follicular fluid was measured by ELISA. TGF-α was detected in oocytes of primordial and early preantral follicles. Furthermore, staining was observed in granulosa cells of preantral follicles and in theca cells of preantral, antral and preovulatory follicles. EGF showed a similar distribution as TGF-α. Atretic follicles were strongly positive for TGF-α and EGF. In the corpus luteum, theca lutein cells were strongly positive for TGF-α and EGF. Immunoreactivity for EGF-R was observed only in the granulosa cells of antral follicles. Follicular fluids from patients undergoing in-vitro fertilization (IVF) were examined for their content of TGF-α and EGF. TGF-α was detected in 37% of the samples. The concentration ranged from 43 pg/ ml to 602 pg/ml. EGF was not detected in any of the follicular fluids tested. These observations support the participation of EGF/TGF-α in follicular maturation. Furthermore, the presence of TGF-α in follicular fluid and the simultaneous absence of EGF suggests that TGF-α plays a more pronounced role than EGF in oocyte maturation during late follicular phase.
Introduction
Our current understanding of the regulation of ovarian function has been extended beyond the classic concept of endocrine regulation mediated by sex steroids and gonadotrophins to include intra-ovarian regulation by paracrine and autocrine factors. Many of the biological events in the ovary, including folliculogenesis, oocyte maturation, the proliferation of granulosa cells and granulosa and luteal cell steroidogenesis, are influenced by growth factors. The presence of several growth factors has been demonstrated in ovarian tissue of various species, and their origin has been associated with their biosynthesis and release by different cell types within the ovary, such as granulosa and theca cells.
Recent reports show that particularly epidermal growth factor (EGF) and its biochemical and physiological relative, transforming growth factor (TGF)-α, stimulate oocyte nuclear and cytoplasmic maturation (Sommer et al., 1992; Ding and Foxcroft, 1994) .
EGF is a 53 amino acid single chain polypeptide with a molecular weight of 6045 Daltons, which was first isolated from the submaxillary gland of the mouse (Cohen, 1962) . TGF-α consists of 50 amino acids and displays a 40% amino acid homology with EGF (Derynck et al., 1984) . Both peptides are secreted as large inactive precursors which become biologically active following proteolytic cleavage. EGF as well as TGF-α displays a mitogenic effect on a variety of mesodermal and ectodermal tissues, and both are highly potent angiogenic agents (Coffey et al., 1987) . Although EGF and TGF-α are products of unlinked genes which are independently regulated, TGF-α binds to the same receptor as EGF, a 170 kDa glycoprotein with tyrosine kinase activity (Hollenberg and Gregory, 1976; Schlessinger, 1986) .
There are several reports indicating the presence and specific cellular production of EGF and TGF-α in ovarian tissue of several different species (Kudlow et al., 1987; Lobb et al., 1989) . However, little is known about the presence and localization of EGF and/or TGF-α and their shared receptor (EGF-R) in human fertile ovaries during the course of follicular maturation and regression.
Materials and methods

Immunohistochemistry
Human ovaries were obtained at autopsy from the Institut für Rechtsmedizin, Ludwig-Maximilians-Universität, Munich, Germany, from women with a history of normal menstrual cycles. The age of the women ranged from 18 to 45 years (mean 30.2 years). Only ovaries with no pathology were used for immunostaining. Sections of normal human kidney and epidermis, known to contain EGF and TGF-α (Elder et al., 1989; Kommoss et al., 1990) , served as positive controls. Immediately after removal, tissues were fixed in 2% formalin for 12 h at room temperature. Tissues were then dehydrated, embedded in paraffin and stored at room temperature.
Normal serum, biotinylated horse anti-mouse IgG, biotinylated goat anti-rabbit IgG and the Vectastain ABC-Elite ® kit were obtained from Vector Laboratories Inc. (Burlingame, CA, USA).
The three primary antibodies, anti-TGF-α, anti-EGF and anti-EGF-R had been raised against the respective antigens from the human by the supplier (Oncogene Science, Manhasset, NY, USA). All primary antibodies were specific and did not inhibit receptor 
n.a. ϭ not applicable; EGF ϭ epidermal growth factor; TGF ϭ transforming growth factor. 
EGF ϭ epidermal growth factor; TGF ϭ transforming growth factor.
binding. Cross reactivity of the primary antibodies to TGF-α and EGF was excluded by radioimmunoassay. Sections 4 µm thick were cut on a microtome and mounted on poly-L-lysine (Sigma, Deisenhofen, Germany) coated Superfrost ® plus glass slides (Menzel, Braunschweig, Germany) . The sections were deparaffinized at 60°C for 30 min, then washed twice with xylol. After rehydration in a graded series of ethanol, they were washed in phosphate buffered saline (PBS, pH 7.4). Subsequently, sections were incubated in freshly prepared 0.3% hydrogen peroxide in absolute methanol to block endogenous peroxidase activity. The sections were again washed in PBS and incubated with 10% normal goat serum (anti-EGF-R) or 10% normal horse serum (anti-EGF and anti-TGF-α) in PBS for 20 min at room temperature. The tissue sections were then incubated with primary antibody in a humidified chamber for 20 h at 4°C. Anti-human EGF and anti-human EGF-R antibodies were used at a dilution of 1:100 in PBS and anti-human TGF-α antibody was used at a 1:500 dilution. Negative controls were incubated in the absence of primary antibody, which was replaced by rabbit non-immune serum (in the case of EGF-R) or irrelevant mouse monoclonal antibody (mAb) MOPC-31C (Sigma) (TGF-α and EGF). The sections were washed extensively and exposed to biotinylated secondary antibody for 30 min at room temperature. The sections were washed again and incubated with freshly prepared avidinbiotinylated horseradish peroxidase complex. The chromogenic reaction was carried out with 3,3Ј-diaminobenzidine (Sigma). Sections were counterstained with Mayer's haematoxylin (Sigma), a coverslip was applied and the slide evaluated using a Zeiss Axiophot ® microscope with photo equipment (Zeiss, Oberkochen, Germany). Serial sections were used to compare the staining pattern of the different primary antibodies. Staining intensity was graded in a semiquantitative 2200 fashion with negative (-), positive (ϩ) and strongly positive immunostaining (ϩϩ). Classification of the staining intensity was performed by only one investigator throughout all experiments to exclude interobserver variability.
Enzyme-linked immunosorbent assay (ELISA)
Human follicular fluids were collected from 54 patients undergoing transvaginal, ultrasound-guided oocyte retrieval for in-vitro fertilization at the IVF Department of the I. Universitätsfrauenklinik, Ludwig-Maximilians-Universität, Munich, Germany. The patients' age ranged from 26 to 47 years (mean 36 years). Prior to oocyte retrieval, ovarian stimulation was achieved by treatment with clomiphene citrate (Ratiopharm, Ulm, Germany, n ϭ 38), clomiphene citrate followed by human menopausal gonadotrophin (HMG, Ferring, Kiel, Germany, n ϭ 8), or triptorelin acetate (Ferring) and HMG (ultrashort protocol) (n ϭ 6). Two women received no hormonal stimulation. At 35 h prior to oocyte retrieval, each patient received a single injection of 5000 IU human chorionic gonadotrophin (HCG, Ferring) intramuscularly.
A total of 62 follicular fluids were collected and immediately frozen at -20°C without dilution or addition of buffer. Only macroscopically clear follicular fluids from oocyte-containing follicles were used for growth factor quantitation. Due to the limited amount of follicular fluid, EGF content was measured in 42 samples, whereas all 62 samples were included in TGF-α analysis.
Quantitative analysis of TGF-α and EGF was performed using commercially available ELISA kits (Oncogene Science, Uniondale, NY, USA). In the TGF-α ELISA kit, both capture and reporter antibodies were affinity purified goat polyclonal antibodies, which were highly specific for mammalian TGF-α and did not cross react with EGF and other related molecules. The detection limit of the assay is 10 pg/ml protein.
The EGF ELISA kit also did not show any cross reactivity to other related proteins, especially not to TGF-α. The capture antibody was a mouse monoclonal antibody, while the reporter antibody was a biotinylated rabbit polyclonal antibody with a detection limit of 10 pg/ml. Follicular fluids were diluted 1:10 in assay buffer, adjusted to pH 7.5 and incubated in duplicates for 2 h in 96-well plates at room temperature with the capture antibody immobilized onto the plastic wells. The plates were washed and incubated with biotinylated 2201 reporter antibody for 90 min at room temperature. The plates were washed again and incubated with freshly prepared streptavidinhorseradish peroxidase for 1 h. After extensive washing, the colour reaction was developed by incubating the wells for 45 min with the substrate-chromogen mixture in the dark, and the reaction product was measured using an automated spectrophotometer (Dynatech MR5000, Denkendorf, Germany). A standard curve using samples with known amounts of TGF-α/EGF was used for quantitation of the spectrophotometrical data. Human urine, which is known to be highly positive for TGF-α and EGF, was diluted 1:100 in assay buffer, adjusted to pH 7.5, and used as a positive control. To evaluate a possible influence of different hormonal stimulation protocols on the amount of TGF-α and EGF in follicular fluids, the results of the above mentioned analysis were grouped according to the stimulation protocol used and compared. Statistical analysis was performed using Student's t-test for non-paired data.
Results
Immunohistochemistry
Immunostaining for EGF and TGF-α was observed in all 18 follicle-containing ovaries. Table I (a,b) summarizes the immunocytochemical localization and staining intensity of EGF and TGF-α in different stages of follicular development.
In primordial and primary follicles, only the oocyte showed intense immunostaining for TGF-α, whereas the stromal cells directly surrounding the follicle were weakly immunostained for TGF-α (Figure 1c, arrow) . In early preantral follicles containing a single layer of cuboid granulosa cells, this monolayer was slightly positive for TGF-α, and the oocyte remained immunoreactive (Figure 1a) . Immunoreactivity for TGF-α in the theca interna cell layer was first observed in the late preantral stage of follicular development (Figure 1c) .
With the increase in follicle size, the intensity of TGF-α immunostaining of the oocyte and the granulosa cells decreased, whereas the staining intensity of the theca interna cells increased. The specific staining pattern for TGF-α in the theca interna cell layer persisted in the antral follicle and further intensified in the preovulatory follicle (Figure 1d, e) . Granulosa cells of the antral or preovulatory follicles showed no presence of TGF-α. Likewise, the surrounding stromal cells of the preantral, antral and preovulatory follicle were negative for TGF-α.
During the initial formation of the corpus luteum, luteinized granulosa and theca interna cells showed strong immunoreactivity for TGF-α, the latter staining more intensely. In the regressing corpus luteum, immunostaining was present only in the peripheral theca lutein cells adjacent to the central scar (Figure 1g ). The corpus albicans was negative for TGF-α.
Stromal cells of the corpus luteum and the corpus albicans showed weak immunostaining.
Atretic follicles displayed intense staining for TGF-α in the former theca interna cells and faint immunostaining in former granulosa cells (Figure 1f ).
Similar to TGF-α staining, EGF-staining was specific in all 18 follicle-containing ovaries. However, there appeared to be some differences in the staining pattern of the two growth factors (compare Table Ia and b) .
In primordial follicles, positive staining for EGF was detected only on the oocyte. The surrounding stromal cells did not show any immunoreactivity. The staining of the oocyte disappeared during the formation of the preantral follicle, while specific staining of the granulosa cells appeared and intensified.
In late preantral follicles no immunostaining for EGF was observed on the oocyte, whereas granulosa and theca interna cells showed weak immunoreactivity. In early antral follicles, the granulosa cells still showed weak immunostaining, whereas the theca interna cell layer was moderately positive for EGF. In theca interna cells, immunostaining for EGF persisted in the late antral follicle, and staining intensity increased as the follicle became larger and matured. In preovulatory follicles, staining intensity of the theca interna cells was stronger than staining of the granulosa cell layer. The stromal cells surrounding the follicles of different stages were negative.
In corpora lutea, both granulosa lutein and theca lutein cells stained positive for EGF with a staining intensity similar to that observed in the granulosa and theca interna cells of the preovulatory follicle. In the regressing corpus luteum, specific staining for EGF disappeared, and in the corpus albicans no immunostaining was detected. The stromal cells surrounding the corpus luteum and the corpus albicans were negative.
In atretic follicles, strong immunostaining for EGF was observed on the theca interna cells only.
When incubated with anti-EGF-R antibody, only the granulosa cells of antral follicles showed specific immunostaining (Figure 1h) . Theca interna cells, stromal cells and the oocyte were negative for EGF-R during all stages of follicular development. Corpus luteum, corpus albicans and atretic follicles did not show any specific staining for EGF-R.
Human renal tissue served as a positive control. When incubated with anti-EGF or anti-TGF-α, it showed positive staining in the epithelium of the distal convoluted tubule as expected (data not shown).
In control experiments, replacement of the specific primary antibodies (anti-TGF-α, anti-EGF, anti-EGF-R) with irrelevant antibodies (MOPC-31C, rabbit IgG) resulted in a lack of specific immunostaining of ovarian or renal tissue (compare Figure 1b) .
TGF-α/EGF in follicular fluid
A total of 62 macroscopically clear oocyte-containing follicular fluids were aspirated from 54 patients and subjected to TGF-α analysis, using the TGF-α ELISA. Quantitation was achieved by comparison to a standard curve, and the concentration of TGF-α in follicular fluid was calculated using the linear regression equation of the standard curve.
We found measurable amounts of TGF-α in 23 of the 62 follicular fluids (37%). The concentration of TGF-α in these follicular fluids ranged from 43 pg/ml to 602 pg/ml (see Figure 2 ). The mean concentration was 306 pg/ml (SD ϭ Ϯ124 pg/ml). All other follicular fluids were negative. Human urine served as a positive control with a TGF-α concentration of 3.2 ng/ml.
Since the follicular fluids were obtained from in-vitro fertilization (IVF) patients undergoing several different hormonal stimulation protocols, TGF-α concentrations resulting from follicles of different stimulation protocols were compared using Student's t-test for non-paired data. Neither the comparison of clomiphene treatment with triptorelin acetate/ HMG, nor of triptorelin acetate/HMG with clomiphene/HMG, nor clomiphene with clomiphene/HMG showed a significant difference at the P ϭ 0.05 level.
For EGF analysis, 41 follicular fluids were measured using ELISA, and the results were compared to a standard curve. The absorbance of all 41 follicular fluids was equal to or below the background absorbance. All follicular fluids measured were therefore considered to be negative for EGF. A positive control of human urine contained 95 ng/ml EGF.
Discussion
This study demonstrates that TGF-α, EGF and their common receptor are localized within the human ovary. During the course of follicular maturation, the localization of these growth factors changes. Using immunohistochemistry, TGF-α was detectable in the oocyte only during the early stages of maturation, when granulosa and theca cells showed no growth factor expression. With further follicular development, staining of the oocyte disappeared, and the granulosa and theca cells began to show TGF-α staining. During late follicular development, only the theca interna cells showed strong immunoreactivity for TGF-α. Also, during the course of follicular regression, theca cells remained strongly positive for TGF-α. The staining pattern for EGF appeared to be similar. The strongest immunoreactivity was observed within the late follicular phase and during regression of the follicle. Granulosa cells showed only weak staining throughout the entire follicular development.
In the corpus luteum, theca lutein cells were strongly positive for TGF-α and EGF, whereas granulosa lutein cells showed weak immunostaining for both growth factors. The corpus albicans was not stained by TGF-α or EGF. Immunoreactivity for EGF-R was observed only in the granulosa cells of antral follicles.
Furthermore, in this study we showed that TGF-α, but not EGF, is present in human follicular fluid.
Our results indicate a regulatory role of TGF-α and EGF during early follicular development. We showed that both growth factors are present in the oocyte, but only in the very early stage of follicular development. Staining intensity decreased in the preantral follicle and finally disappeared.
During the early follicular stages the recruitment of follicles for further development takes place. Still, the process of recruitment is poorly understood. Factors that promote the growth and differentiation of granulosa cells during the follicular phase are follicle-stimulating hormone (FSH), oestradiol and TGF-β (Bendell and Dorrington, 1991) . TGF-α and EGF in turn are potential inhibitors of FSH and have a dosedependent inhibitory effect on FSH-induced aromatase activity (Adashi and Resnick, 1986; Dorrington et al., 1987; Lobb et al., 1988) . This results in a decrease of oestradiol concentrations in the ovary and finally leads to a suppression of follicular development (Bendell and Dorrington, 1990; Mason et al., 1990) .
Boland and Gosden (1994) described a dose-dependent effect of EGF on the follicular maturation of mouse follicles. A concentration of 1 ng/ml in the culture medium led to an increased number of preovulatory follicles, whereas a higher concentration of 5 or 10 ng/ml EGF produced an increased rate of atretic follicles. In addition, Westergaard and Andersen (1989) compared the amount of EGF and EGF-like factors in follicular fluids and found the highest concentration in small follicles, 2 mm in diameter.
These results together with our observation of TGF-α and EGF being present in the oocyte of primordial and primary follicles, suggest a regulatory role of these growth factors in the early developmental stage of the follicle. Possibly, TGF-α/EGF can prevent or at least influence the recruitment of a primordial follicle for further growth and maturation.
In our study, both growth factors were localized predominantly in theca cells of large follicles, with their common receptor being present on granulosa cells of large follicles. These findings indicate a specific influence of TGF-α and EGF during further follicular maturation. Apart from their importance in small growing follicles, TGF-α and EGF also exert multiple effects during late follicular development and oocyte maturation. Both growth factors have been shown to stimulate granulosa cell differentiation in vitro (Dekel and Sherizly, 1985; Yeh et al., 1993) . In the presence of inhibitors of meiosis, both TGF-α and EGF have been reported to induce resumption of meiotic maturation in cumulus cell-enclosed mouse oocytes in vitro (Downs et al., 1988; Brucker et al., 1991) . TGF-α has been reported to mimic the action of luteinizing hormone (LH) on preovulatory follicles (Tsafriri et al., 1989) , inducing progesterone synthesis. Recent reports suggest a role for EGF in nuclear and cytoplasmic maturation of porcine oocytes (Sommer et al., 1992; Ding and Foxcroft, 1994) . Another major role for TGF-α and EGF is their influence on steroidogenesis. In granulosa cell cultures, the combination of FSH with either EGF or TGF-α produces a synergistic stimulation of progesterone and 20α-dihydroprogesterone production (Yeh et al., 1993) . Luciano et al. (1994) presented a study indicating the important role of progesterone in preventing granulosa cell apoptosis, thus regulating the survival especially of the large granulosa cells. While both small and large granulosa cells are present within the rat ovary, only the large granulosa cells secrete oestrogen and progesterone (Lederer et al., 1993; Sanbuissho et al., 1993) . Apparently, enhanced progesterone synthesis is an essential part of the mechanism by which EGF and TGF-α maintain large granulosa cell viability and thereby regulate steroidogenesis of the granulosa cells. Furthermore, Tilly et al. (1992) showed that TGF-α and EGF inhibit granulosa cell apoptosis in vitro. Billig et al. (1996) indicated that TGF-α and EGF play an important role in preventing apoptosis of granulosa cells in preovulatory follicles. In various studies FSH and LH were shown to have an anti-apoptotic effect only when added to cultured follicles, but not in cultured granulosa cells. This indicates the importance of the theca cell compartment as a mediator of intercellular signals. Billig et al. (1996) postulated that FSH and LH induce the production of IGF-I in granulosa cells, which then acts on theca cells to stimulate TGF-α and EGF secretion. Again, both growth factors are then thought to diffuse back to the granulosa cells to inhibit apoptosis.
The site of TGF-α/EGF production in the ovary has been investigated by others. TGF-α mRNA was detected in bovine (Skinner and Coffey, 1988) and rat (Kudlow et al., 1987) ovaries and in human ovarian carcinoma (Kommoss et al., 1992) . Recent studies in the human ovary indicate that TGF-α mRNA is predominantly localized in the theca cells (Tamura et al., 1995) . In our study, TGF-α immunoreactivity was predominantly observed in the theca cells of the growing follicle, and EGF-R was localized on the granulosa cells only. These findings support the evidence that TGF-α is produced in theca cells and exerts a paracrine effect on follicles via the EGF-R on granulosa cells.
In the same study by Tamura et al. (1995) , EGF mRNA was not detected in human follicles, implying that EGF may be synthesized in non-follicular cells. Yeh et al. (1993) showed that TGF-α mRNA, but not EGF mRNA, is found in rat granulosa cells. These observations, as well as the discrepancy between the presence of TGF-α and the absence of EGF in the fluids of preovulatory follicles in our own study, suggest that TGF-α as a locally produced EGF-R ligand may play a more pronounced role in the autocrine/paracrine regulation of follicular maturation than EGF.
The site of production of TGF-α and EGF differs from the localization of the corresponding receptor. Also, TGF-α is present in the follicular fluid, which is not in direct contact with the apparent site of TGF-α production, the compartment occupied by the theca cells. Therefore, the existence of an intercellular pathway between the different compartments of the follicle is only implied. Larsen et al. (1987) described the presence of gap junctions between the oocyte and membrana granulosa as well as cumulus cells. The number of these gap junctions declines just before the resumption of meiosis of the oocyte. During the follicular phase in which TGF-α and EGF exert their biological effect on oocyte maturation (Downs et al., 1988; Brucker et al., 1991) , these gap junctions may play a role in growth factor distribution within the follicle.
Recently, the occurrence of highly specialized cell types of the granulosa and cumulus oophorus was described by Antczak et al. (1997) . They observed a novel method of growth factor storage and release in certain cells of the preovulatory follicle, which express tethered structures on their surface. Apparently, these structures can accumulate cellular peptides, such as leptin, VEGF and TGF-β. These peptides apparently are sequestered in membrane-bound structures and then discharged 2204 in a direct and regulated manner. Although the presence of TGF-α within the tethered structures has not been demonstrated, such a mechanism could explain the presence of TGF-α in follicular fluid, despite the fact that TGF-α producing cells are not directly attached to the fluid-containing compartment. Taken together, these data support the hypothesis postulated by Billig et al. (1996) , i.e. that TGF-α is produced in theca cells, then diffuses to the granulosa cells. After binding to the EGF-R, the receptor-growth factor complex is internalized and TGF-α might be sequestered into the follicular fluid by the above mentioned tethered structures.
EGF was immunohistochemically localized in the human ovaries of this study, but was not detected by ELISA in follicular fluids from human preovulatory follicles in women who underwent ovarian stimulation. These results are consistent with previous studies. Hsu et al. (1987) detected an EGF-like activity in porcine follicular fluid using a radio receptor assay, while a radioimmunoassay (RIA) using polyclonal anti-EGF was negative. The level of EGF-like activity was greater in small follicles than in larger follicles. Westergaard and Andersen (1989) found measurable concentrations of EGF in human follicular fluids of small and preovulatory follicles by RIA. They described a decline in EGF concentration with the increase in follicle diameter. These observations and the lack of EGF in follicular fluids from human preovulatory follicles in our study suggest that intrafollicular EGF may play a more pronounced role in the local regulation of follicular growth and function earlier than the preovulatory stage of development, while TGF-α may be involved in the auto-or paracrine regulation of follicle and oocyte maturation. The mitogenic effect of EGF on human granulosa cells in vitro is in fact more pronounced when these originate from smaller follicles than from larger ones (Gospodarowicz and Bialecki, 1979) .
However, in our study EGF was also immunohistochemically localized in late antral and preovulatory follicles. This discrepancy between the presence of EGF in the cells of the late developmental stage of the follicle and the obvious absence in the follicular fluid in follicles of the same stage is not yet explained. There may be different mechanisms involved that influence receptor binding, transport and degradation of the biochemically different molecules of EGF and TGF-α. One can also speculate that there is a factor in the granulosa cells preventing sequestration of EGF into the follicular fluid.
Finally, the expression of EGF and TGF-α in the theca interna cells of atretic follicles and theca lutein cells in the regressing corpus luteum implies that TGF-α and EGF may participate in the transformation of theca cells into stromal cells to remodel ovarian tissue following luteolysis and atresia.
In this study we showed that TGF-α and EGF are present in different cells of the human ovary and that TGF-α is also present in the follicular fluid of preovulatory follicles. These findings support the role of both growth factors as intraovarian regulators of early follicular selection and growth in the human ovary. Furthermore, the results of the analysis of follicular fluids may suggest a greater effect of TGF-α as compared to EGF during late follicular maturation.
